Stocks Health care ZLAB
NASDAQ · Health careZai Lab Ltd (ZLAB)
Zai Lab Ltd brought in $449.6M of revenue over the twelve months to June 30, 2026, up 5.1% from a year earlier. It posted a net loss of $188.2M. In fiscal 2025 capital spending exceeded operating cash flow by $158.9M. At June 30, 2026 it held $607.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Zai Lab Ltd does
Zai Lab Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ZLAB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $460.2M | -$175.5M | -$0.16 | -$158.9M |
| 2024 | $399M | -$257.1M | -$0.26 | -$220.5M |
| 2023 | $266.7M | -$334.6M | -$0.35 | -$205.4M |
| 2022 | $215M | -$443.3M | -$0.46 | -$392.2M |
| 2021 | $144.3M | -$704.5M | -$0.76 | -$567.5M |
| 2020 | $49M | -$268.9M | -$0.35 | -$226.2M |
Latest SEC filings
What Zai Lab Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- June 17, 2026
- June 11, 2026Passive stake (5% or more) SCHEDULE 13G
- May 21, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
- April 28, 2026
- April 28, 2026Additional proxy material DEFA14A
- April 28, 2026Proxy statement DEF 14A
Questions about ZLAB
What does Zai Lab Ltd do?
Zai Lab Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ZLAB.
Is Zai Lab Ltd profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $188.2M on revenue of $449.6M.
How much revenue does Zai Lab Ltd make?
Over the twelve months to June 30, 2026 Zai Lab Ltd reported revenue of $449.6M. That is 5.1% more than a year earlier.
When did Zai Lab Ltd last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 21, 2026.
Similar companies
Follow ZLAB
Get an email when Zai Lab Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow ZLAB: get an email when it filesWhere the numbers come from
Financial figures are the values Zai Lab Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.